Dionaldo, Fred Steve G.
HRN: 14-48-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
CEFUROXIME 750MG (VIAL)
10/03/2023
10/10/2023
IV
750mg
Q8hrs
Fracture Radius Ulna R
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes